Trials / Completed
CompletedNCT01235819
Comparison Between GLP 1 Analogues and DPP 4 Inhibitors in Type 1 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Command Hospital, India · Other Government
- Sex
- All
- Age
- 12 Years – 30 Years
- Healthy volunteers
- Not accepted
Summary
To study the effects of GLP 1 analogues and DPP 4 inhibitors on newly detected type 1 diabetes patients.
Detailed description
Inclusion criteria T1DM \<3 months GAD Antibody+ Stimulated C peptide\<0.5ng/ml Ketosis at onset Age \< 30 yr Exclusion criteria Age \> 30 yr Pancreatic disease significant systemic complication
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Insulin | Exenatide Sitagliptin |
| DRUG | Sitagliptin | Sitagliptin 100 mg per day oral |
| DRUG | Exenatide | Exenatide 10 micrograms daily twice |
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2010-11-08
- Last updated
- 2016-07-27
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT01235819. Inclusion in this directory is not an endorsement.